These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1105560)

  • 21. Intravenous pulse cyclophosphamide treatment of severe lupus nephritis: a prospective five-year study.
    Valeri A; Radhakrishnan J; Estes D; D'Agati V; Kopelman R; Pernis A; Flis R; Pirani C; Appel GB
    Clin Nephrol; 1994 Aug; 42(2):71-8. PubMed ID: 7955581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children.
    Tangnararatchakit K; Tapaneya-Olarn C; Tapaneya-Olarn W
    J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S104-10. PubMed ID: 10730528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of acute systemic lupus erythematosus with intravenous infusions of cyclophosphamide. Value and limitations].
    De Bandt M; Goycochea MV; Meyer O; Delahousse M; Palazzo E; M'Bappé P; Kahn MF
    Ann Med Interne (Paris); 1994; 145(2):75-87. PubMed ID: 8024184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The course of chronic glomerulonephritis in chronic opisthorchiasis].
    Beloborodova EI; Zibnitskaia LI; Kaliuzhina EV
    Ter Arkh; 2005; 77(11):44-9. PubMed ID: 16404862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of combined immunosuppressive anticoagulant and antiplatelet therapy of the course of chronic mesangial-proliferative glomerulonephritis.
    Matousovic K; Matl I; Zabka J; Zástava V; Rossmann P; Prát V
    Czech Med; 1985; 8(3):151-7. PubMed ID: 3932033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytotoxic drug treatment of lupus nephritis.
    Donadio JV; Holley KE; Ilstrup DM
    Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):178-81. PubMed ID: 7102666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclophosphamide-induced ovarian failure.
    Warne GL; Fairley KF; Hobbs JB; Martin FI
    N Engl J Med; 1973 Nov; 289(22):1159-62. PubMed ID: 4754963
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunosuppressive therapy in adults with proliferative glomerulonephritis. Controlled trial.
    Booth LJ; Aber GM
    Lancet; 1970 Nov; 2(7681):1010-3. PubMed ID: 4098045
    [No Abstract]   [Full Text] [Related]  

  • 29. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.
    du Buf-Vereijken PW; Branten AJ; Wetzels JF;
    Nephrol Dial Transplant; 2004 May; 19(5):1142-8. PubMed ID: 14993502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide.
    Mok CC; Ying KY; Ng WL; Lee KW; To CH; Lau CS; Wong RW; Au TC
    Am J Med; 2006 Apr; 119(4):355.e25-33. PubMed ID: 16564783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of effects of the intravenous cyclophosphamide treatment of primary glomerulonephritis and the estimation of complications].
    Strazmester-Majstorović G; Mitić I; Ilić T; Celić D; Milosević A; Curić S
    Med Pregl; 2007; 60 Suppl 2():62-5. PubMed ID: 18928160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A controlled trial of cyclophosphamide in patients with membranous glomerulonephritis.
    West ML; Jindal KK; Bear RA; Goldstein MB
    Kidney Int; 1987 Oct; 32(4):579-84. PubMed ID: 3323596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The treatment of chronic glomerulonephritis with ultrahigh doses of cyclophosphane].
    Krasnova TN; Shilov EM; Ivanov AA; Samoĭlov DV; Gordovskaia NB; Miroshnichenko NG; Tareeva IE
    Ter Arkh; 1991; 63(6):115-8. PubMed ID: 1948725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous cyclophosphamide for lupus nephritis in Thai children.
    Vachvanichsanong P; Dissaneewate P; Winn T
    Scand J Rheumatol; 2004; 33(5):339-42. PubMed ID: 15513684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis.
    Conlon PJ; Fischer CA; Levesque MC; Smith SR; St Clair EW; Allen NB; Fleming JA; Howell DN
    Clin Nephrol; 1996 Sep; 46(3):170-5. PubMed ID: 8879851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunosuppressive therapy of glomerulonephritis--controlled studies].
    Ferrari P; Frey FJ
    Ther Umsch; 1993 Feb; 50(2):119-29. PubMed ID: 8456416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of chronic glomerulonephritis using indomethacin and small doses of cyclophosphamide].
    Vanrenteghem Y; Roels L; Verberckmoes R; Michielsen P
    J Urol Nephrol (Paris); 1975; 81(4-5):281-90. PubMed ID: 1159887
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunosuppressive therapy and clinical evolution in forty-nine patients with antineutrophil cytoplasmic antibody-associated glomerulonephritis.
    Kokolina E; Alexopoulos E; Dimitriadis C; Vainas A; Giamalis P; Papagianni A; Ekonomidou D; Memmos D
    Ann N Y Acad Sci; 2005 Jun; 1051():597-605. PubMed ID: 16127000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The course and prognosis of mesangioproliferative glomerulonephritis].
    Shilov EM; Tareeva IE; Ivanov AA; Troepol'skaia OV; Krasnova TN; Varshavskiĭ VA; Proskurneva EP; Ivanova LV; Khudova IIu; Miroshnichenko NG
    Ter Arkh; 2002; 74(6):11-8. PubMed ID: 12136475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Controlled therapeutic trial in IgA glomerulonephritis].
    Belovezhdov N; Robeva R
    Vutr Boles; 1982; 21(3):49-53. PubMed ID: 7051564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.